Explanation
igabatrin
Viaabatrinisassociated withvisuaufielddefects.Theonsetof svmptomsvariesfrom1monthtoseveraLyears
after startinqtherapyv.In mostcases.visuaLfielddefects persist despite discontinuationofthedrua.visuatfed
assessmentshouldbecarried outbeforetreatmentandat6-monthintervals.andpatientsshouldbewarned
toreportany newvisualsymptomsthatdevelopsotheycan bereferredfor an urgemt ophthalmoloqicat
viaabatrin shouldbeconsidered
opiniomgraduaL withdrawat
@1MINENDOCRINE
